Company intelligence / Profile preview

BioAgilytix

Durham, North Carolina, United Statesau.linkedin.com ↗

Ownership: Private
Employees: ~500
Development stage: Commercial

Overview

BioAgilytix does not have its own clinical results or pipeline. It provides bioanalytical testing and assay development for pharmaceutical and biotech clients at all phases of drug development—from discovery through clinical trials to post-market surveillance—specializing in large molecule therapeutics such as biologics and cell/gene therapies. The company has an industry reputation for quality data integrity and regulatory compliance.

Modalities: Monoclonal antibodyAntibody-drug conjugateCell therapyGene therapyBiosimilarBiologicSmall molecule
Industry: Contract Research Organization

Partnerships

Partners with many top global pharmaceutical and biotechnology companies as clients.

Beyond the preview

Go deeper on BioAgilytix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioAgilytix.

Explore the full profile